We are live on
!
Find out more
SMC
Smith, Moore & Co Portfolio holdings
AUM
$1.54B
1-Year Est. Return
24.82%
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
+24.82%
3 Year Est. Return
+67.03%
5 Year Est. Return
+71.32%
10 Year Est. Return
+222.13%
AUM
$655M
AUM Growth
-$8.3M
(-1.3%)
Cap. Flow
+$6.32M
Cap. Flow
% of AUM
0.96%
Top 10 Holdings %
Top 10 Hldgs %
33.91%
Holding
436
New
29
Increased
202
Reduced
107
Closed
20
Avg Time Held
12.8
quarters
Top 10 Avg Time Held
24.2
quarters
Top 20 Avg Time Held
18.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacer Lunt Large Cap Alternator ETF
ALTL
|
+$4.23M |
| 2 |
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
|
+$2.13M |
| 3 |
American Century Quality Diversified International ETF
QINT
|
+$1.24M |
| 4 |
BlackRock Science and Technology Term Trust
BSTZ
|
+$1.03M |
| 5 |
Leggett & Platt
LEG
|
+$1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$4.3M |
| 2 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$1.61M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$1.49M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
+$1.24M |
| 5 |
Locust Walk Acquisition Corp. Unit
LWACU
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 65.49% |
| 2 | Technology | 5.35% |
| 3 | Healthcare | 5.19% |
| 4 | Financials | 4.19% |
| 5 | Industrials | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
VanEck Junior Gold Miners ETF
GDXJ
$8.2B
| $2.63M | 0.4% |
68,723
+981
| +1% | +$42.1K |
2016 Q2
21 quarters
|
|
52
Pfizer
PFE
$162B
| $2.59M | 0.4% |
60,269
-5
| -0% | -$222 |
2013 Q4
31 quarters
|
|
53
iShares Russell 2000 Value ETF
IWN
$13.8B
| $2.59M | 0.39% |
16,150
+124
| +0.8% | +$19.9K |
2016 Q4
19 quarters
|
|
54
SPDR Gold Trust
GLD
$141B
| $2.57M | 0.39% |
15,660
-56
| -0.4% | -$9.37K |
2013 Q4
31 quarters
|
|
55
iShares MSCI Emerging Markets ETF
EEM
$30.5B
| $2.48M | 0.38% |
49,263
-60
| -0.1% | -$3.12K |
2013 Q4
31 quarters
|
|
56
Verizon
VZ
$181B
| $2.45M | 0.37% |
45,287
+2,860
| +7% | +$158K |
2014 Q1
30 quarters
|
|
57
Emerson Electric
EMR
$91.2B
| $2.41M | 0.37% |
25,598
-191
| -0.7% | -$19.1K |
2013 Q4
31 quarters
|
|
58
Union Pacific
UNP
$168B
| $2.38M | 0.36% |
12,169
+9
| +0.1% | +$1.94K |
2017 Q3
16 quarters
|
|
59
iShares Core MSCI International Developed Markets ETF
IDEV
$33B
| $2.37M | 0.36% |
35,446
-1,377
| -4% | -$94.2K |
2018 Q4
11 quarters
|
|
60
iShares MSCI EAFE ETF
EFA
$76.8B
| $2.35M | 0.36% |
30,131
-35
| -0.1% | -$2.8K |
2013 Q4
31 quarters
|
|
61
iShares Core US Aggregate Bond ETF
AGG
$137B
| $2.35M | 0.36% |
20,438
+370
| +2% | +$42.9K |
2013 Q4
31 quarters
|
|
62
iShares Silver Trust
SLV
$28.8B
| $2.28M | 0.35% |
111,088
+7,605
| +7% | +$171K |
2013 Q4
31 quarters
|
|
63
PepsiCo
PEP
$173B
| $2.21M | 0.34% |
14,669
-214
| -1% | -$33.1K |
2013 Q4
31 quarters
|
|
64
Berkshire Hathaway Class B
BRK.B
$1.11T
| $2.08M | 0.32% |
7,602
+219
| +3% | +$61.5K |
2014 Q1
30 quarters
|
|
|
65
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
$197M
| $2.07M | 0.32% |
+53,735
| New | +$2.13M |
2021 Q3
0 quarters
|
|
66
Bristol-Myers Squibb
BMY
$116B
| $1.98M | 0.3% |
33,376
+1,233
| +4% | +$81.2K |
2015 Q1
26 quarters
|
|
67
ProShares S&P SmallCap 600 Dividend Aristocrats ETF
SMDV
$656M
| $1.96M | 0.3% |
31,802
+4,177
| +15% | +$262K |
2018 Q4
11 quarters
|
|
68
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.32B
| $1.92M | 0.29% |
25,496
-15,309
| -38% | -$1.19M |
2016 Q1
22 quarters
|
|
69
Honeywell
HON
$65.7B
| $1.87M | 0.29% |
9,335
-191
| -2% | -$40.7K |
2015 Q4
23 quarters
|
|
70
Vanguard Morningstar Small-Cap ETF
VB
$77.9B
| $1.77M | 0.27% |
8,100
-383
| -5% | -$85.1K |
2020 Q1
6 quarters
|
|
71
iShares Core Dividend Growth ETF
DGRO
$43.2B
| $1.76M | 0.27% |
34,964
+6,621
| +23% | +$343K |
2020 Q4
3 quarters
|
|
72
Schwab US Broad Market ETF
SCHB
$45.3B
| $1.72M | 0.26% |
99,354
-19,650
| -17% | -$349K |
2015 Q3
24 quarters
|
|
73
Coca-Cola
KO
$388B
| $1.71M | 0.26% |
32,555
+25
| +0.1% | +$1.39K |
2013 Q4
31 quarters
|
|
74
Visa
V
$744B
| $1.71M | 0.26% |
7,665
+29
| +0.4% | +$6.8K |
2015 Q4
23 quarters
|
|
75
Viatris
VTRS
$19.8B
| $1.62M | 0.25% |
119,382
+35,344
| +42% | +$501K |
2021 Q1
2 quarters
|
|
Similar funds
AWC
FP
SPC
LCM
CP
KCM
HCM
BFG
Smith, Moore & Co's Q3 2021 Portfolio in Review
As of Q3 2021, Smith, Moore & Co held 436 positions worth $655M, down 1.3% from $664M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Smith, Moore & Co's Q3 2021 filing shows 29 new, 202 increased, 107 reduced and 20 closed positions. Its largest new stake was Pacer Lunt Large Cap Alternator ETF: 99,184 shares worth $4.08M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $4.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 66% a quarter earlier, followed by Technology and Healthcare.
- Smith, Moore & Co's largest Q3 2021 buy was Pacer Lunt Large Cap Alternator ETF: 99,184 shares worth $4.08M.
- Smith, Moore & Co added most to BlackRock Science and Technology Term Trust in Q3 2021, an estimated $1.03M increase.
- Smith, Moore & Co's biggest Q3 2021 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $4.3M.
- Smith, Moore & Co fully exited iShares MSCI USA Value Factor ETF in Q3 2021, selling an estimated $1.61M.
- Smith, Moore & Co's ten largest holdings make up 34% of its $655M portfolio in Q3 2021.
- Smith, Moore & Co opened 29 new positions and closed 20 in Q3 2021.
- Smith, Moore & Co's portfolio value fell 1.3% quarter-over-quarter to $655M.
Based on Smith, Moore & Co's 13F filing for Q3 2021, filed 12 Nov 2021.